95 related articles for article (PubMed ID: 24607243)
1. Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.
Cianfarani S; Inzaghi E; Alisi A; Germani D; Puglianiello A; Nobili V
J Pediatr; 2014 Jul; 165(1):92-8. PubMed ID: 24607243
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
4. Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.
Street ME; Smerieri A; Montanini L; Predieri B; Iughetti L; Valenzise M; De Luca F; Vigone M; Weber G; Maghnie M; Bernasconi S
J Biol Regul Homeost Agents; 2013; 27(1):259-66. PubMed ID: 23489706
[TBL] [Abstract][Full Text] [Related]
5. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
6. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease.
Hribal ML; Procopio T; Petta S; Sciacqua A; Grimaudo S; Pipitone RM; Perticone F; Sesti G
J Clin Endocrinol Metab; 2013 Feb; 98(2):E304-8. PubMed ID: 23316084
[TBL] [Abstract][Full Text] [Related]
10. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
Runchey SS; Boyko EJ; Ioannou GN; Utzschneider KM
J Gastroenterol Hepatol; 2014 Mar; 29(3):589-96. PubMed ID: 24716226
[TBL] [Abstract][Full Text] [Related]
12. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
Alisi A; Pampanini V; De Stefanis C; Panera N; Deodati A; Nobili V; Cianfarani S
PLoS One; 2018; 13(7):e0201566. PubMed ID: 30063751
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model].
Zhang Q; Zhang ZX; Fang Q; Gao FY; Zhao QL; Yang Y; Su HM; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):196-200. PubMed ID: 22475139
[TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
[TBL] [Abstract][Full Text] [Related]
15. [Changes in concentrations of circulating insulin-like growth factors I and II and binding proteins BP-2 and BP-3 in children treated for acute lymphoblastic leukaemia].
Krawczuk-Rybak M; Kitszel A; Wołczyński S
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):15-20. PubMed ID: 15355735
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
17. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor (IGF) binding protein-3 and IGF-I levels during childhood and adolescence. A cross-sectional study.
Andrade Olivié MA; García-Mayor RV; González Lestón D; Rodríguez Sousa T; Segura Dominguez A; Alvarez-Novoa R; Antelo Cortizas J
Pediatr Res; 1995 Aug; 38(2):149-55. PubMed ID: 7478808
[TBL] [Abstract][Full Text] [Related]
19. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors].
Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U
Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
